Search For "biopharma"
SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expan
Updated : 2 weeks, 3 days ago IST
San Jose [Costa Rica]/ Raichur (Karnataka) [India], February 25: SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated biopharmaceutical subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), announce a
Read More
Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing a
Updated : 1 month ago IST
Piscataway (New Jersey) [US], February 11: Kashiv BioSciences, LLC ("Kashiv") a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals Ltd ("Intas"), a leading multinational pharmaceutic
Read More
Strengthening Translational Research in India: GVSAP and Biocytogen Expand
Updated : 1 month, 1 week ago IST
Hyderabad (Telangana) [India], February 5: GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: 02315), a global biotechnology company that drive
Read More
Budget 2026 positions India to accelerate from volume-driven production to
Updated : 1 month, 1 week ago IST
The Union Health Budget 2026 has unveiled a push to the healthcare sector that will. make country self reliable and long term globally credible.
Read More
Budget reinforces long-term biopharma growth despite no new tax incentives
Updated : 1 month, 1 week ago IST
The Union Budget 2026 has signalled a sustained policy push for India's pharmaceutical and life sciences sector, with a strong emphasis on biopharma innovation, research infrastructure and affordability, even as direct tax incentives remain unchanged, noted EY's Budget sectoral alert.
Read More
Budget fulfils aspirations of Uttar Pradesh: UP CM Yogi Adityanath
Updated : 1 month, 1 week ago IST
Uttar Pradesh Chief Minister Yogi Adityanath on Monday lauded the Union Budget 2026-27, asserting that the budget fulfils the aspirations of Uttar Pradesh with its special focus on Micro Small, and Medium Enterprises (MSME) sector.
Read More
Industry chambers applaud Budget 2026 for strengthening India's biopharma
Updated : 1 month, 1 week ago IST
The Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, healthcare, and grassroots entrepreneurship. Industry experts hail the government for their push for strengthening the country's biopharma sector, as we
Read More
Budget 2026: Sitharaman allocates Rs 10000 crore to make India biopharma h
Updated : 1 month, 1 week ago IST
Finance Minister Nirmala Sitharaman has proposed to push India's biopharma sector under a Bio Pharma Shakti programme with an allocation of Rs 10000 crore for the next 5 years.
Read More
Samsung Biologics to invest USD 4.8 billion in new Songdo bio campus
Updated : 3 months, 1 week ago IST
Samsung Biologics has announced a massive investment of 7 trillion won (about USD 4.8 billion) to build its third bio campus in Songdo, Incheon, marking another step toward expanding its global biopharmaceutical production and advancing next-generation drug manufacturing technologies, as per
Read More
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuzn
Updated : 3 months, 2 weeks ago IST
Singapore, November 26: Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar d
Read More
MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at
Updated : 4 months ago IST
Hong Kong, November 10: Shanghai, November 10, 2025 - During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("MediTrust Health") signed a strategic cooperation agreement. The two partie
Read More
VAV Lipids to Back IIT Bombay's LipidVerse 2025 as Industry Expert
Updated : 4 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], October 31: VAV Lipids, a global leader in lipid technology and biopharmaceutical solutions, has announced it will support Indian Institute of Technology Bombay (IIT Bombay) to present the inaugural LipidVerse 2025 Conference. VAV Lipids will leverage its positi
Read More